N-(4-Cyanophenyl)glycine CAS 42288-26-6
Shanghai Ruifu Chemical est primarius fabrica glycinerum N-(4-Cyanophenyl)glycini (CAS: 42288-26-6) cum qualitate media Dabigatran Etexilate Mesylate (CAS: 872728-81-9).Ruifu Chemical traditio terrarum, quantitatis competitive, parvae et quantitatis quantitatis in promptu est, praebere potest.N-(4-Cyanophenyl)glycine,Please contact: alvin@ruifuchem.com
| Nomen chemicum | N-(4-Cyanophenyl)glycine |
| Synonyma | Dabigatran Etexilate Intermediate 2;N-(p-Cyanophenyl)glycine;N-(4-Cyano-Phenyl)-Glycine;2-[(4-Cyanophenyl)amino] aceticum Acidum;2-(4-Cyanophenylamino) aceticum Acidum;Dabigatran Cyanopheny Impuritas |
| Stock Status | In Stock, Commercial Productio |
| CAS Number | 42288-26-6 |
| Formulae hypotheticae | C9H8N2O2 |
| M. Pondus | 176.18 g/mol |
| Liquescens punctum | 227.0~230.0℃ |
| Density | 1.30±0.10 g/cm3 |
| COA & MSDS | Praesto |
| Free Sample | Praesto |
| Origin | Shanghai, China |
| Categoria | Dabigatran Etexilate Mesylate (CAS: 872728-81-9) |
| Brand | Ruifu Chemical |
| Items | Specifications | Proventus |
| Aspectus | Alba ad Off-White pulveris | Off-Pulvis alba |
| Liquescens punctum | 227.0~230.0℃ | 227.0~228.0℃ |
| Damnum in Siccatio | <0.50% | 0.09% |
| Residere in Ignition | <0.50% | 0.26% |
| Asssay / Analysis Methodo | 98.0%~ 102.0% | 100.6% |
| Puritas / Analysis Methodus | >99.0% (HPLC) | 99.5% |
| 4-Aminobenzonitrile | <1.00% | Obsequitur |
| Alia immunitas | <0.25% | <0.25% |
| Totalis immunditias | <1.00% | 0.50% |
| Metalla gravis | <10ppm | <10ppm |
| 1H NMR Imaginum | Congruunt Structure | Obsequitur |
| conclusio | Productum probatum est et cum datis specificationibus obsequitur | |
| Applicationem | Dabigatran Etexilate Mesylate (CAS: 872728-81-9) | |
Sarcina:Fluorinated Utrem, aluminium ffoyle, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Continentem arcte clausam et in frigido, sicco et bene ventilato horreis a substantiis incompossibilibus repone.A sole abstinete;ignem vitare;humorem vitare.
Naviportans:Libera ad mundum ab aere, per FedEx / DHL Express.Ieiunium et certas traditiones provide.
| Mobile phase | Solutio quiddam (0.025mol/L KH2PO4, pH=3.1): Acetonitrile=60:40 |
| Columna | Kromasil 100-5 C18 250*4.6mm*5μm |
| Dilute | Aqua:Acetonitrile=50:50 |
| Fluere | 1.0mL/min |
| Columna Temperature | 25℃ |
| Curre Tempus | 30min |
| Necem | 254nm |
| Iniectio Volume | 10μL |
Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
glycine (CAS: 42288-26-6), media Dabigatran Etexilate Mesylate (CAS: 872728-81-9).Dabigatran Etexilatus nova synthetica directa thrombin inhibitor est.Praecursor est dabigatran et non peptide thrombin inhibitor.Post administrationem oralem, Dabigatran etexilatus in dabigatran cum actione anticoagulante in vivo mutata est.Dabigatran ligat fibrinae locum specificum thrombin ligaminis et impedit fibrinogenum ne fibrino adhaereat, ita ultimum gradum retis coagulationis cascade et thrombosi claudens.Dabigatran a thrombin conjugato fibrino discernere potest et effectum anticoagulantem convertibilem ludere.
